Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
K-
K-
Revenue could be +20+% ($120+M?) vs Q1 and CF +/-0 (or positive) in Q2.
Best,
G
d-
between signing of the contract and 12/31/2017: 108,503k
in 2018: 14,928k (sums to 123,431k as of 12/31/2018 ... between signing of the contract and 12/31/2018)
in 2019: 17,974k (sums to 142,405k as of 12/31/2019 ... between signing of the contract and 12/31/2019)
in 2020: 24,952k (sums to 166,357k as of 12/31/2020 ... between signing of the contract and 12/31/2020)
in 2021: 9,976k (sums to 176,333k as of 20/30/2021 ... between signing of the contract and 06/30/2021)
was paid, sums to 176,333k (26,166,436 USD)
Best,
G
d-
d-
Good summary.
Best,
G
K-
K-
B-
Thx for your summary / "impressions".
Best,
G
K-
z-
K-
z-
r-
K-
K- (& to all)
K-
s-
I have a huge backlog (have to "clean out" my "ticker collection") so I am not up-to-date re. CFRX.
Best,
G
i-
i-
K-
K-
r- (and to whom it concerns)
Thx, but please note my question was as
r-
f-
(Fire) Cushion bodes well ... is a perfect fit ... both for reality and dreams ...
Best,
G
xxx-
Seriously ... we are seeing it on the internet: do not you think we have access to the chart(s)?
Useless post(s) ...
l-
You are right, my bad.
Best,
G
K-
It were not trades, it were posts by "the" TA guru ...
Best,
G
K-
Don't be fooled ... "interestingly" AMRN is the "only one" that worth a post ....
Amarin Corp. PLC ADS (AMRN) / 05/13/2022 12:58:56 PM / 2,950
QID, QLD Trading (QQQ) / 02/21/2022 12:39:22 PM / 1
Humanigen Inc. (HGEN) / 05/28/2021 08:31:01 AM / 2
Ocugen, Inc (OCGN) / 05/27/2021 05:51:09 PM / 1
NorthWest Biotherapeutics Inc. (NWBO) / 05/18/2021 01:14:43 PM / 23
Direxion Small Cap Bear 3X (TZA) / 12/23/2017 09:31:55 AM / 2
NASDAQ & QQQ Analysis and Trends / 12/23/2017 09:03:34 AM / 1
Best,
G
r-
Hi man,
69,722
Best,
G
w-
K- (&CaptBeer #377350)
b-
d-
l-
K-
a.) the cash-flow SG&A was $86M ... will be (avg.) $75-76M (as a result of the $30M cut ... see Q1 call)
b.) The US portion (defined as U.S. gross profit less U.S. sales and marketing-related* expenses) has positive contribution margin. app. $193M and $11M in FY2021 and Q1 (Note: *in my calculation inc. ex-US expenses also, since no breakdown available … Profit from U.S. commercial activities is higher.)
Best,
G
b-
T-
r-
r-
I do not say I fully analyzed (understand) the UK process but:
- I think NICE recommendation is not binding but usually followed
- Unless something (first of all the requested price: £173 per pack of 120 capsules) was change since the last draft guidance I expect a "Icosapent ethyl is not recommended" since "£34,067 per QALY" vs "an acceptable ICER would be below £20,000 per QALY"
Best,
G